Latest Financial Position News

CAR Group Ltd reported a robust half-year performance for the period ending December 31, 2024, with revenue up 9% and profit growth across all key markets. The company declared a 38.5 cents per share interim dividend, underscoring its strong financial position and confidence in future growth.

JB Hi-Fi Limited reported a robust half-year performance for the period ending December 31, 2024, with revenue up 9.9% and net profit rising 8.1%, underpinned by strong segment contributions and a strategic acquisition. The company declared a healthy interim dividend of 170 cents per share, signalling confidence in its financial position.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Hotel Property Investments (HPI) reported a solid $16.7 million statutory profit for H1 FY25, alongside a 3.2% rise in distributions and a successful debt refinancing that extends maturity and reduces costs.

Nick Scali Limited has announced a fully franked ordinary dividend of AUD 0.30 per share for the six months ending December 2024, signaling steady shareholder returns.

Nick Scali Limited’s half-year results reveal a 30.2% decline in statutory profit, impacted by UK acquisition losses and restructuring costs, yet the company maintains shareholder returns with a fully franked interim dividend.

Garda Property Group has reaffirmed its FY25 income return at 7.2 cents per security and upgraded its distribution payout ratio to 95% of FFO. The group plans to sell its North Lakes industrial site for $114 million and is marketing its Cairns Corporate Tower, aiming to reduce gearing and reposition as a focused industrial REIT.

Apollo Minerals has successfully raised $2 million through a shortfall offer, anchored by a strategic investment from Capital DI Limited, positioning the company to accelerate exploration at its Salanie Gold Project in Gabon.

Vitrafy Life Sciences reports strong progress in cryopreservation technology development and US market expansion following a successful $35 million IPO. The company highlights improved biological sample preservation outcomes and strategic commercial milestones.

Vitrafy Life Sciences reported a dramatic increase in half-year losses to $25.7 million, yet successfully raised $35 million through an IPO to fuel its cryopreservation technology expansion.

Loyal Lithium unveils a strategic pivot to broaden its North American lithium and battery technology portfolio, leveraging new US energy policies and $5.5 million in funding to capitalize on the continent’s evolving energy grid demands.

Novo Resources has significantly expanded its Australian exploration footprint through three new high-potential farm-in and joint venture agreements, while maintaining a robust financial position with A$12.1 million in cash and A$43.8 million in investments.